Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTT | P42858 | 3/20 | 0.51 |
| ▸ | MAPT | P10636 | 4/20 | 0.49 |
| ▸ | LMNA | P02545 | 4/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.49 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.49 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.49 |
| ▸ | GAA | P10253 | 1/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.45 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.45 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.42 |
| ▸ | HPGD | P15428 | 1/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.40 |
| ▸ | KCNA3 | P22001 | 1/20 | 0.40 |
| ▸ | PDE4A | P27815 | 1/20 | 0.40 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.40 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4779654 | 0.88 | LMNA (0.51) | HTTMAPTLMNAALDH1A1TDP1 | |
| SCHEMBL10740410 | 0.85 | LMNA (0.56) | HTTMAPTLMNAALDH1A1TDP1 | |
| SCHEMBL4309406 | 0.85 | MAPT (0.62) | HTTMAPTLMNAALDH1A1TDP1 | |
| SCHEMBL1421887 | 0.84 | ALDH1A1 (0.59) | HTTMAPTLMNAALDH1A1TDP1 | |
| SCHEMBL30069060 | 0.84 | ALDH1A1 (0.59) | HTTMAPTLMNAALDH1A1TDP1 | |
| SCHEMBL16513023 | 0.83 | HTT (0.50) | HTTMAPTLMNAALDH1A1TDP1 | |
| SCHEMBL6667907 | 0.82 | ALDH1A1 (0.43) | HTTMAPTLMNAALDH1A1TDP1 | |
| SCHEMBL5512898 | 0.81 | MAPT (0.58) | HTTMAPTLMNAALDH1A1TDP1 | |
| SCHEMBL23302233 | 0.80 | HTT (0.58) | HTTMAPTLMNATDP1MEN1 | |
| SCHEMBL17041239 | 0.79 | ALDH1A1 (0.41) | HTTMAPTLMNAALDH1A1TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0674233-B1 | Recording sheets | XEROX CORP (US) | 2000-05-24 | — | — | EP | claimed |
| US-5928765-A | Recording sheets | XEROX CORPORATION (US) | 1999-07-27 | — | — | US | claimed |
| EP-0674233-A2 | Recording sheets | XEROX CORPORATION (US) | 1995-09-27 | — | — | EP | claimed |
| WO-2021085321-A1 | RESIN COMPOSITION, RESIN SHEET, CURED FILM, METHOD FOR MANUFACTURING CURED FILM, SEMICONDUCTOR DEVICE, ORGANIC EL DISPLAY DEVICE, AND DISPLAY DEVICE | 東レ株式会社 | 2021-05-06 | — | — | WO | disclosed |
| US-20160096795-A1 | COMPOUNDS AND METHODS FOR PREPARATION OF DIARYLPROPANES | UNIGEN INC (US) | 2016-04-07 | — | — | US | disclosed |
| US-9045405-B2 | Compounds and methods for preparation of diarylpropanes | UNIGEN, INC. (US) | 2015-06-02 | — | — | US | disclosed |
| US-20140235899-A1 | COMPOUNDS AND METHODS FOR PREPARATION OF DIARYLPROPANES | UNIGEN, INC. (US) | 2014-08-21 | — | — | US | disclosed |
| WO-2012129260-A1 | COMPOUNDS AND METHODS FOR PREPARATION OF DIARYLPROPANES | UNIGEN, INC. (US) | 2012-09-27 | — | — | WO | disclosed |
| US-20120245393-A1 | COMPOUNDS AND METHODS FOR PREPARATION OF DIARYLPROPANES | UNIGEN, INC. (US) | 2012-09-27 | — | — | US | disclosed |
| US-20070208086-A1 | UBIQUINONE ANALOGS AND METHODS OF USE | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2007-09-06 | — | — | US | disclosed |
| US-20070208086-A1 | UBIQUINONE ANALOGS AND METHODS OF USE | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2007-09-06 | — | — | US | disclosed |
| US-20070203080-A1 | New Drug Delivery System for Crossing the Blood Brain Barrier | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2007-08-30 | — | — | US | disclosed |
| WO-2007095630-A2 | NEW UBIQUINONE ANALOGS AND METHODS OF USE | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2007-08-23 | — | — | WO | disclosed |
| WO-2007095630-A2 | NEW UBIQUINONE ANALOGS AND METHODS OF USE | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2007-08-23 | — | — | WO | disclosed |
| WO-2007095631-A2 | NEW DRUG DELIVERY SYSTEM FOR CROSSING THE BLOOD BRAIN BARRIER | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2007-08-23 | — | — | WO | disclosed |
| WO-2007095631-A2 | NEW DRUG DELIVERY SYSTEM FOR CROSSING THE BLOOD BRAIN BARRIER | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2007-08-23 | — | — | WO | disclosed |
| EP-0674233-B1 | Recording sheets | XEROX CORP (US) | 2000-05-24 | — | — | EP | disclosed |
| US-5928765-A | Recording sheets | XEROX CORPORATION (US) | 1999-07-27 | — | — | US | disclosed |
| EP-0674233-A2 | Recording sheets | XEROX CORPORATION (US) | 1995-09-27 | — | — | EP | disclosed |
| US-5451458-A | Electrography | XEROX CORPORATION (US) | 1995-09-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160096795-A1 | COMPOUNDS AND METHODS FOR PREPARATION OF DIARYLPROPANES | DDT, QDPR, NPY1R | HTT 1099/4885MAPT 208/4885LMNA 514/4885 |
| US-20120245393-A1 | COMPOUNDS AND METHODS FOR PREPARATION OF DIARYLPROPANES | DDT, QDPR, NPY1R | HTT 1099/4885MAPT 208/4885LMNA 514/4885 |
| US-20140235899-A1 | COMPOUNDS AND METHODS FOR PREPARATION OF DIARYLPROPANES | DDT, QDPR, NPY1R | HTT 1099/4885MAPT 208/4885LMNA 514/4885 |
| US-20070208086-A1 | UBIQUINONE ANALOGS AND METHODS OF USE | NDUFB7, NDUFB1, NDUFB3 | HTT 1214/4885MAPT 4254/4885LMNA 1593/4885 |
| US-20070203080-A1 | New Drug Delivery System for Crossing the Blood Brain Barrier | NDUFB5, NDUFB7, NDUFB3 | HTT 1242/4885MAPT 1404/4885LMNA 2544/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.